TSH Biopharm Corporation Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 105.294 million compared to TWD 90.750 million a year ago. Operating income was TWD 18.005 million compared to TWD 9.704 million a year ago. Net income was TWD 13.044 million compared to TWD 8.109 million a year ago. Basic earnings per share from continuing operations was TWD 0.34 compared to TWD 0.21 a year ago. For the half year, sales was TWD 207.041 million compared to TWD 222.739 million a year ago. Operating income was TWD 30.014 million compared to TWD 41.084 million a year ago. Net income was TWD 22.727 million compared to TWD 31.792 million a year ago. Basic earnings per share from continuing operations was TWD 0.59 compared to TWD 0.83 a year ago.